Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers
Kanika Vanshylla, Chengcheng Fan, Marie Wunsch, et al.
Cell Host & Microbe (2021) Vol. 30, Iss. 1, pp. 69-82.e10
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Antibody-mediated neutralization of SARS-CoV-2
Henning Gruell, Kanika Vanshylla, Timm Weber, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 925-944
Open Access | Times Cited: 117
SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns
Henning Gruell, Kanika Vanshylla, Michael Korenkov, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 9, pp. 1231-1241.e6
Open Access | Times Cited: 71
Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant
Aurélien Sokal, Matteo Broketa, Giovanna Barba‐Spaeth, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 1096-1104.e4
Open Access | Times Cited: 51
Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
Cyril Planchais, I. Fernández, Timothée Bruel, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 7
Open Access | Times Cited: 51
Protective neutralizing epitopes in SARS‐CoV‐2
Hejun Liu, Ian A. Wilson
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 76-92
Open Access | Times Cited: 39
Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies
Qingrui Huang, Xiaonan Han, Jinghua Yan
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2412-2422
Open Access | Times Cited: 30
Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
Emanuele Andreano, Ida Paciello, Silvia Marchese, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Enhanced SARS-CoV-2 humoral immunity following breakthrough infection builds upon the preexisting memory B cell pool
Timm Weber, Sabrina Dähling, S. Rose, et al.
Science Immunology (2023) Vol. 8, Iss. 89
Closed Access | Times Cited: 19
Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variants
Michael Korenkov, Matthias Zehner, Hadas Cohen‐Dvashi, et al.
Immunity (2023) Vol. 56, Iss. 12, pp. 2803-2815.e6
Open Access | Times Cited: 17
Breakthrough infection elicits hypermutated IGHV3-53/3-66 public antibodies with broad and potent neutralizing activity against SARS-CoV-2 variants including the emerging EG.5 lineages
Ling Li, Xixian Chen, Zuowei Wang, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 12, pp. e1011856-e1011856
Open Access | Times Cited: 15
An ultra-long heavy chain bovine antibody neutralizes SARS-CoV-2 and reacts broadly with sarbecoviruses
Theocharis Tsoleridis, Chengcheng Fan, Emily J. Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2
Manish Dhawan, Nanamika Thakur, Manish Sharma, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117936-117936
Closed Access
Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies
Pradeepa Pushparaj, Andrea Nicoletto, Daniel J. Sheward, et al.
Immunity (2022) Vol. 56, Iss. 1, pp. 193-206.e7
Open Access | Times Cited: 26
Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies
John P. Evans, Shan‐Lu Liu
The Journal of Immunology (2023) Vol. 211, Iss. 10, pp. 1459-1467
Open Access | Times Cited: 13
Rapid Hypermutation B Cell Trajectory Recruits Previously Primed B Cells Upon Third SARS-Cov-2 mRNA Vaccination
Lisa Paschold, Bianca Klee, Cornelia Gottschick, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Application of germline antibody features to vaccine development, antibody discovery, antibody optimization and disease diagnosis
Yingjie Zhang, Qing Li, Liang Luo, et al.
Biotechnology Advances (2023) Vol. 65, pp. 108143-108143
Closed Access | Times Cited: 10
Potent NTD-Targeting Neutralizing Antibodies against SARS-CoV-2 Selected from a Synthetic Immune System
Wenping Li, Fulian Wang, Yu Li, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 771-771
Open Access | Times Cited: 9
Delineating antibody escape from Omicron sublineages
Henning Gruell, Kanika Vanshylla, Michael Korenkov, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Closed Access | Times Cited: 15
Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2
Cyril Planchais, I. Fernández, Timothée Bruel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 14
Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages
Mark Chernyshev, Mrunal Sakharkar, Ruth I. Connor, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 8
The unique ORF8 protein from SARS-CoV-2 binds to human dendritic cells and induces a hyper-inflammatory cytokine storm
Matthias Hamdorf, Thomas Imhof, Ben A. Bailey-Elkin, et al.
Journal of Molecular Cell Biology (2023) Vol. 15, Iss. 10
Open Access | Times Cited: 8
Novel Competitive ELISA Utilizing Trimeric Spike Protein of SARS-CoV-2, Could Identify More Than RBD-RBM Specific Neutralizing Antibodies in Hybrid Sera
Petros Eliadis, Annie Mais, Alexandros Papazisis, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 914-914
Open Access | Times Cited: 2
Challenges and Progress in Designing Broad-Spectrum Vaccines Against Rapidly Mutating Viruses
Rishi Bedi, Nicholas Bayless, Jacob Glanville
Annual Review of Biomedical Data Science (2023) Vol. 6, Iss. 1, pp. 419-441
Open Access | Times Cited: 7
Single-cell analysis of memory B cells from top neutralizers reveals multiple sites of vulnerability within HCMV Trimer and Pentamer
Matthias Zehner, Mira Alt, Artem Ashurov, et al.
Immunity (2023) Vol. 56, Iss. 11, pp. 2602-2620.e10
Open Access | Times Cited: 7
Discovery and characterization of SARS-CoV-2 reactive and neutralizing antibodies from humanized CAMouseHG mice through rapid hybridoma screening and high-throughput single-cell V(D)J sequencing
Xi Yang, Hang Chi, Meng Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top